Health economic assessment tools (HEAT) for walking and for cycling : methodology and user guide : economic assessment of transport infrastructure and policies : 2014 update by Kahlmeier, Sonja et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2014
Health economic assessment tools (HEAT) for walking and for cycling :
methodology and user guide : economic assessment of transport
infrastructure and policies : 2014 update
Kahlmeier, Sonja; Kelly, Paul; Foster, Charlie; Götschi, Thomas; Cavill, Nick; Dinsdale, Hywell;
Woodcock, James; Schweizer, Christian; Rutter, Harry; Lieb, Christoph; Pekka, Oja; Racioppi,
Francesca
Abstract: Unspecified
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-104829
Published Version
Originally published at:
Kahlmeier, Sonja; Kelly, Paul; Foster, Charlie; Götschi, Thomas; Cavill, Nick; Dinsdale, Hywell; Wood-
cock, James; Schweizer, Christian; Rutter, Harry; Lieb, Christoph; Pekka, Oja; Racioppi, Francesca
(2014). Health economic assessment tools (HEAT) for walking and for cycling : methodology and user
guide : economic assessment of transport infrastructure and policies : 2014 update. Copenhagen: World
Health Organization.
 ECONOMIC ASSESSMENT OF 
TRANSPORT INFRASTRUCTURE 
AND POLICIES
Health economic assessment tools 
(HEAT) for walking and for cycling
Methods and user guide, 2014 update
The 2011 version of this publication arose from the project “PHAN”, which received funding from the 
European Union in the framework of the Health Programme. The 2014 version is an updated reprint.
The views expressed herein can in no way be taken to reflect the official opinion of the European Union.
Health economic assessment tools 
(HEAT) for walking and for cycling 
Methodology and user guide, 2014 update 
ECONOMIC ASSESSMENT OF 
TRANSPORT INFRASTRUCTURE 
AND POLICIES
Sonja Kahlmeier, University of Zurich, Switzerland
Paul Kelly, Oxford University, United Kingdom 
Charlie Foster, Oxford University, United Kingdom 
Thomas Götschi, University of Zurich, Switzerland 
Nick Cavill, Cavill Associates, United Kingdom
Hywell Dinsdale, Public Health Analyst, Hyde, United Kingdom
James Woodcock, Institute of Public Health, Cambridge, United Kingdom
Christian Schweizer, WHO Regional Office for Europe
Harry Rutter, London School of Hygiene and Tropical Medicine, United Kingdom 
Christoph Lieb, Ecoplan, Bern, Switzerland  
Pekka Oja, UKK Institute for Health Promotion Research, Finland 
Francesca Racioppi, WHO Regional Office for Europe
Keywords 
BICYCLING 
WALKING
TRANSPORTATION METHODS – ECONOMICS 
HEALTH ECONOMICS
COST-BENEFIT ANALYSIS – METHODS 
DATA COLLECTION – METHODS 
GUIDELINES
EUROPE
© World Health Organization 2011, updated reprint 2014
All rights reserved. The Regional Office for Europe of the 
World Health Organization welcomes requests for permission 
to reproduce or translate its publications, in part or in full.
The designations employed and the presentation of the 
material in this publication do not imply the expression of 
any opinion whatsoever on the part of the World Health 
Organization concerning the legal status of any country, 
territory, city or area or of its authorities, or concerning the 
delimitation of its frontiers or boundaries. Dotted lines on 
maps represent approximate border lines for which there 
may not yet be full agreement.
The mention of specific companies or of certain 
manufacturers’ products does not imply that they are 
endorsed or recommended by the World Health Organization 
in preference to others of a similar nature that are not 
mentioned. Errors and omissions excepted, the names of 
proprietary products are distinguished by initial capital 
letters.
All reasonable precautions have been taken by the World 
Health Organization to verify the information contained in 
this publication. However, the published material is being 
distributed without warranty of any kind, either express or 
implied. The responsibility for the interpretation and use of 
the material lies with the reader. In no event shall the World 
Health Organization be liable for damages arising from 
its use. The views expressed by authors, editors, or expert 
groups do not necessarily represent the decisions or the 
stated policy of the World Health Organization.
ISBN: 978-92-890-0251-6
Address requests about publications of the  
WHO Regional Office for Europe to:
 
Publications
WHO Regional Office for Europe 
UN City 
Marmorvej 51 
DK-2100 Copenhagen Ø,  Denmark
Alternatively, complete an online request form 
for documentation, health information, or for permission 
to quote or translate, on the WHO/Europe web site 
(http://www.euro.who.int/pubrequest). 
iii
Contents 
Contributors and acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
1. Introduction .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  1
2.   Methodological guidance on economic appraisal of health effects 
related to walking and cycling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
 2.1.  Walking and cycling data.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 5
 2.2.  Time needed to reach full level of walking or cycling . . . . . . . . . . . . . . . . . . . . . . 5
 2.3.   Interactions between transport-related physical activity, air pollution  
and road traffic injuries .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 5
 2.4.  Mortality or morbidity? .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 6
 2.5.  The nature of the relationship between physical activity and health  . . . . . . . . . . . . 6 
 2.6.  Age groups .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 8
 2.7.  Sex . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
 2.8.  Time needed for health benefits to build up.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 8
 2.9.  Activity substitution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  8
 2.10.  Seasonality and regional differences in cycling and walking . . . . . . . . . . . . . . . . . 9
 2.11.  Static vs life tables approach.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 9
 2.12.  Costs applied  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
 2.13.  Discounting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
 2.14.  Sensitivity analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
3.  Reviews of the literature: summary  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11
 3.1.  Economic literature  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
 3.2.  Epidemiological literature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
4.  The HEAT for walking and for cycling: introduction .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 15
 4.1. General principles of the tool  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
 4.2. Who is the tool for?.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  15
 4.3. What can the tool be used for? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
 4.4. What should the tool not be used for?  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
 4.5. Basic functioning of the tool .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  18
 4.6. What input data are needed? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
 4.7. Data sources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
 4.8. What data will the tool produce? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
5.  HEAT for walking: instructions for user . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  23
 5.1. How to access the tool  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
 5.2. How to use the tool: five simple steps .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  23
iv
 5.3. Assumptions .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  28
6.  HEAT for cycling: instructions for users . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
 6.1. How to access the tool  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
 6.2. How to use the tool: five simple steps .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  29
 6.3. Assumptions .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  33
References  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
v2014 update
International advisory group 
• Karim Abu-Omar, University of Erlangen, 
Germany
• Lars Bo Andersen, School of Sports Science, 
Norway
• Finn Berggren, Gerlev Physical Education and 
Sports Academy, Denmark
• Tegan Boehmer, Centers for Disease Control 
and Prevention, United States of America
• Nils-Axel Braathen, Organisation for Economic 
Co-operation and Development, France
• Audrey de Nazelle, University College London, 
United Kingdom
• Jonas Finger, Robert Koch Institute, Germany
• Eszter Füzeki, Johann Wolfgang Goethe-
Universität, Germany
• Frank George, WHO Regional Office for Europe
• Regine Gerike, University of Natural Resources 
and Life Sciences Vienna, Austria
• Marie-Eve Heroux, WHO Regional Office for 
Europe
• Michal Krzyzanowski, King’s College London, 
United Kingdom 
• I-Min Lee, Harvard School of Public Health, 
United States of America
• Nanette Mutrie, University of Edinburgh, 
United Kingdom
• Luc Int Panis, VITO, Belgium
• Laura Perez, Swiss Tropical and Public Health 
Institute, Switzerland
• David Rojas Rueda, Centre for Research in 
Environmental Epidemiology, Spain
• Peter Schantz, Swedish School of Sport and 
Health Sciences, Sweden
• Heini Sommer, Ecoplan, Switzerland
Acknowledgements
This 2014 updated reprint of HEAT for walking 
and for cycling was supported by the German 
Federal Ministry for the Environment, Nature 
Conservation, Building and Nuclear Safety. The 
third consensus workshop (Bonn, Germany, 
1–2 October 2013) was chaired by Michal 
Krzyzanowski, King’s College London, facilitated 
by the University of Zurich, Switzerland 
and carried out in collaboration with the 
Universitätsclub Bonn e.V.
The authors thank Aiden Doherty, Anja Mizdrak, 
Justin Richards, Nia Roberts, Peter Scarborough, 
Andrew Wright of Oxford University for 
contributing to the systematic reviews on 
cycling and walking and all-cause mortality (see 
section 3.2) and Dareskedar Workie, University 
of Alberta, Canada, for input to the economic 
valuation approach (see section 3.1). 
HEAT for walking (2010–2011) 
Lead authors
• Hywell Dinsdale, National Obesity Observa-
tory England, United Kingdom
• Nick Cavill, Cavill Associates, United Kingdom
• Sonja Kahlmeier, University of Zurich, 
Switzerland
Project core group
• Dushy Clarke, Oxford University, United 
Kingdom
Contributors and acknowledgements
vi
• Richard Fordham, University of East Anglia, 
United Kingdom
• Charlie Foster, Oxford University, United 
Kingdom
• Thomas Götschi, University of Zurich, 
Switzerland
• Paul Kelly, Oxford University, United Kingdom
• Pekka Oja, UKK Institute for Health Promotion 
Research, Finland
• Francesca Racioppi, WHO Regional Office for 
Europe
• Harry Rutter, National Obesity Observatory 
England, United Kingdom
• Dave Stone, Natural England, United Kingdom
International advisory group
• Lars Bo Andersen, School of Sports Science, 
Norway
• Andy Cope, Sustrans, United Kingdom
• Mark Fenton, Tufts University, USA
• Mark Hamer, University College London, 
United Kingdom
• Max Herry, Herry Consult, Austria
• I-Min Lee, Harvard School of Public Health, 
USA
• Brian Martin, University of Zurich, Switzerland
• Markus Maybach and Christoph Schreyer, 
Infras, Switzerland
• Marie Murphy, University of Ulster, United 
Kingdom
• Gabe Rousseau, Federal Highway Administra- 
tion, USA
• Candace Rutt and Tom Schmid, Centers for 
Disease Control and Prevention, USA
• Elin Sandberg and Mulugeta Yilma, Road 
Administration, Sweden
• Daniel Sauter, Urban Mobility Research, 
Switzerland
• Peter Schantz, Mid Sweden University and 
Swedish School of Sport and Health Sciences
• Peter Schnohr, Copenhagen City Heart Study, 
Denmark
• Christian Schweizer, WHO Regional Office for 
Europe
• Heini Sommer, Ecoplan, Switzerland
• Jan Sørensen, Centre for Applied Health 
Services Research and Technology Assess-
ment, University of Southern Denmark
• Gregor Starc, University of Ljubljana, Slovenia
• Wanda Wendel Vos, National Institute for 
Health and Environment, Netherlands
• Paul Wilkinson, London School of Hygiene 
and Tropical Medicine, United Kingdom
Acknowledgements
The development of HEAT for walking was 
supported by a consortium of donors from the 
United Kingdom under the leadership of Natural 
England. The consortium included the Depart- 
ment of Health England, Environment Agency, 
the Countryside Council for Wales, Public Health 
Wales, the Physical Activity & Nutrition Networks 
for Wales, the Forestry Commission and the Scot- 
tish Government, Public Health Directorate. It 
was also supported by the Swiss Federal Office 
of Public Health and by the WHO Regional Office 
of Europe. It was financially supported by the 
European Union in the framework of the Health 
Programme 2008–2013 (Grant agreement 2009 
52 02). The views expressed herein can in no 
way be taken to reflect the official opinion of the 
European Union.
The consensus workshop on walking (Oxford, 
United Kingdom, 1–2 July 2010) was facilitated 
by the University of Oxford.
vii
HEAT for cycling (2007–2010)
Project core group
• Nick Cavill, Cavill Associates, United Kingdom
• Hywell Dinsdale, South East Public Health 
Observatory, United Kingdom
• Sonja Kahlmeier, WHO Regional Office for 
Europe
• Pekka Oja, Karolinska Institute, Sweden
• Francesca Racioppi, WHO Regional Office for 
Europe
• Harry Rutter, South East Public Health Obser-
vatory, United Kingdom
International advisory group 
• Lars Bo Andersen,* School of Sports Science, 
Norway
• Finn Berggren, Gerlev Physical Education and 
Sports Academy, Denmark
• Hana Bruhova-Foltynova, Charles University 
Environment Centre, Czech Republic
• Fiona Bull, Loughborough University, United 
Kingdom
• Andy Cope,* Sustrans, United Kingdom
• Ardine de Wit and Wanda Wendel Vos, 
National Institute for Health and Environment, 
Netherlands
• Maria Hagströmer and Michael Sjöström, 
Karolinska Institute, Sweden
• Eva Gleissenberger and Robert Thaler, Lebens- 
ministerium, Austria
• Brian Martin, Federal Office of Sport, 
Switzer- land
• Irina Mincheva Kovacheva, Ministry of Health, 
Bulgaria
• Hanns Moshammer, International Society of 
Doctors for the Environment
viii
• Bhash Naidoo, National Institute for Health 
and Care Excellence, United Kingdom
• Åse Nossum and Knut Veisten, Institute for 
Transport Economics, Norway
• Kjartan Sælensminde, Norwegian Directorate 
for Health and Social Affairs, Norway
• Peter Schantz,* Research Unit for Movement, 
Health and Environment, Åstrand Laboratory, 
Swedish School of Sport and Health Sciences, 
Sweden
• Thomas Schmid, Centers for Disease Control 
and Prevention, USA
• Heini Sommer,* Ecoplan, Switzerland
• Jan Sørensen,* Centre for Applied Health Ser- 
vices Research and Technology Assessment, 
University of Southern Denmark
• Sylvia Titze, University of Graz, Austria
• Mulugeta Yilma, Road Administration, Sweden
Acknowledgements
The development of HEAT for cycling was 
supported by the Austrian Federal Ministry of 
Agriculture, Forestry, Environment and Water 
Management, Division V/5 – Transport, Mobil- 
ity, Human Settlement and Noise and by the 
Swedish Expertise Fund, and facilitated by 
the Karolinska Institute, Sweden. The project 
benefited greatly from systematic reviews 
being undertaken for the National Institute for 
Health and Care Excellence (NICE) in the United 
Kingdom. The consensus workshop on cycling 
(Graz, Austria, 15–16 May 2007) was facilitated 
by the University of Graz.
*Members of the extended core group
Pilot testing (HEAT for walking and for cycling, 
2010)
• Hana Bruhova-Foltynova, Charles University
• Environment Centre, Czech Republic
• Sean Co, Metropolitan Transportation Com- 
mission, Oakland, California, USA
• Werner Hagens, Liesbeth Mathijssen, Yonne 
Mulder, National Institute for Public Health 
and the Environment (RIVM), Netherlands
• Ruth Hunter, Centre for Public Health, Queen’s 
University Belfast, United Kingdom
• Sam Margolis, LBTH and NHS Tower Hamlets, 
United Kingdom
• Angela Wilson, Research and Monitoring Unit, 
Sustrans, United Kingdom
External expert review (2010 edition)
• Paul Curtis, London European Partnership for 
Transport, United Kingdom
• Adrian Lord, Arup, United Kingdom
• Nanette Mutrie, University of Strathclyde, 
Glasgow, United Kingdom
Web programming and design of 
www.heatwalkingcycling.org: Duy Dao, 
Switzerland
Editing: Frank Theakston and David Breuer, 
Denmark
Layout: Lars Møller, Denmark
Photos: WHO/Nicoletta di Tanno (pp. 4, 7, 14, 26); 
Fotolia (Cover, pp. vii, 1, 5, 11, 15, 17, 23); Istock: 
(p. ix, 29).
ix
1Physical inactivity is a significant public health 
problem in most regions of the world, which 
is unlikely to be solved by classical health 
promotion approaches alone. The promotion 
of active transport (cycling and walking) for 
everyday physical activity is a win-win approach; 
it not only promotes health but can also lead 
to positive environmental effects, especially 
if cycling and walking replace short car trips. 
Cycling and walking can also be more readily 
integrated into people’s busy schedules than, 
for example, leisure-time exercise. These forms 
of physical activity are also more practicable for 
groups of the population for which sport is either 
not feasible because of physical limitations or is 
not an accessible leisure activity for economic, 
social or cultural reasons. There is a large 
potential for active travel in European urban 
transport, as many trips are short and would 
be amenable to being undertaken on foot or 
by bicycle. This, however, requires effective 
partnerships with the transport and urban 
planning sectors, whose policies are key driving 
forces in providing appropriate conditions for 
such behavioural changes to take place. This has 
been recognized by a number of international 
policy frameworks, such as the Action Plan for 
implementation of the European Strategy for the 
Prevention and Control of Noncommunicable 
Diseases 2012–2016, adopted by the WHO 
Regional Committee for Europe (1). The strategy 
identifies the promotion of active mobility as 
one of the supporting interventions endorsed 
by WHO Member States to address this high- 
priority topic in the European Region, as do other 
international policy frameworks such as the 
Toronto Charter for Physical Activity launched 
in May 2010 as a global call for action (2).
Transport is an essential component of life and a 
basis for providing access to goods and services. 
Different modes of transport are associated 
with specific impacts on society, including 
health, environment and social effects. Fully 
appraising these effects is an important basis 
for evidence- based policy-making. Economic 
appraisal is an established practice in transport 
planning. However, techniques for assessing 
the economic value of the benefits to health 
of cycling and walking have historically been 
applied less systematically than the approaches 
used for assessing the other costs and benefits 
of new infrastructure.
Valuing health effects is a complex undertaking, 
and transport planners are often not well 
1 Introduction 
2equipped to fully address the methodological 
complexities involved. A few countries in Europe, 
such as those working through the Nordic 
Council (Denmark, Finland, Iceland, Norway 
and Sweden), have carried out pioneering work 
in trying to assess the overall costs and benefits 
of transport infrastructures taking health effects 
into account, and guidance for carrying out such 
assessments has been developed. Nevertheless, 
important questions have remained.
Coordinated by WHO, three project phases were 
carried out aimed at developing guidance and 
practical tools for economic assessments of the 
health effects from (a) cycling and (b) walking. 
First published in 2007 and officially launched in 
2009, a methodological guidance report (3) and 
a health economic assessment tool (HEAT) for 
cycling (4) were presented. In 2011, an updated 
online version of the HEAT for cycling and a HEAT 
for walking (5) were published. In 2014, the HEAT 
for walking and cycling were again updated (6). 
Implementation of the projects was steered 
by a core project group, which worked in 
close collaboration with advisory groups of 
international experts (see the list of contributors 
above). These experts were specifically selected 
to represent an interdisciplinary range of 
professional backgrounds and expertise, 
including health and epidemiology, health 
economics, transport economics, a practice and/ 
or advocacy perspective, and policy development 
and implementation. Close coordination also 
took place with the Transport, Health and 
Environment Pan-European Programme (THE 
PEP) and HEPA Europe (the European network 
for the promotion of health-enhancing physical 
activity).
The key project steps were as follows.
• The project core group commissioned sys-
tematic reviews (a) of published economic 
valuations of transport projects, including a 
physical activity element (2007 (7) and 2010) 
and (b) of epidemiological literature with 
regard to health effects from cycling and 
walking, particularly for transport (2010 and 
2013).
• The results of these reviews were considered 
by the core group and used to propose 
options for and guidance towards a more 
harmonized methodology.
• Draft methodological guidance and practical 
tools for cycling and for walking were devel-
oped and tested, and piloted by members of 
the advisory group.
• International consensus meetings with the 
advisory groups on walking and on cycling, 
respectively, were held in 2007, 2010 and 
2013 to facilitate discussion and the achieve-
ment of scientific consensus on the options 
proposed in the draft methodological guid-
ance and tools.
• Based on the meeting recommendations, 
further bilateral discussions with different 
members of the advisory group and extensive 
pilot testing by additional experts, the prod-
ucts of each project phase were approved for 
publication. These included: a guidance docu-
ment (3) and a methodology and user guide 
(5), an online tool for walking and for cycling 
(6) (based on a previous, Excel-based version 
for cycling only (4)) and this publication. 
Scientific publications include a systematic 
review of the economic literature (7), a pub-
lication on HEAT for cycling applications (8) 
and a publication on the initial HEAT cycling 
methods (9). 
This publication represents a summary of 
these products. Chapter 2 presents the main 
conclusions on the methods for economic 
assessment of transport infrastructure and 
policies regarding inclusion of the health effects 
3of walking and cycling. Chapter 3 contains the 
main results of systematic reviews of economic 
and health literature.
The principles outlined in the guidance have 
been applied in two web-based, practical 
calculation tools, showing how the methodology 
can be used to assess health effects related to 
walking or to cycling, respectively. The main 
principles are outlined in Chapter 4. The tools are 
available online (6). If you are mainly looking for 
guidance on applying the HEAT tools, please go 
directly to Chapter 4 and then read Chapter 5 
and/or Chapter 6, which contain detailed user 
guides with instructions for walking and cycling, 
respectively, and outline potential limitations 
of the approach. Further hints and tips can be 
found online. 
Knowledge of the health effects of cycling 
and walking is evolving rapidly. These projects 
represent important steps towards agreed 
harmonized methods. In developing these 
tools, on several occasions the advisory 
groups made expert judgements based on 
the best available information and evidence. 
Therefore, the accuracy of results of the HEAT 
calculations should be understood as estimates 
of the order of magnitude, much like many other 
economic assessments of health effects. Further 
improvements will be made as new knowledge 
becomes available. 
Feedback to further improve the tools and 
maximize their user-friendliness is welcome at: 
heat@euro.who.int.
4
5This chapter summarizes the key methodological 
issues concerning the economic appraisal of 
health effects related to walking and cycling. 
A more extensive discussion of these issues, 
including options for and guidance towards a 
more harmonized methodology for the economic 
appraisal of the health effects of walking and 
cycling, has been published previously (3). The 
conclusions of this earlier report were updated 
in 2010 and 2013 in view of new evidence (see 
also Chapter 3).
2.1. Walking and cycling data
The quality of economic appraisals is highly 
dependent on the validity and reliability of 
the walking and cycling data used. In many 
countries, systematic long-term surveys of 
cycling and walking are not yet available or they 
do not provide local-level data, which are often 
needed for the appraisal of a local transport 
intervention or infrastructure.
When using data from local surveys, it must be 
ensured that they are representative for the 
population assessed with the HEAT. The studies 
should have been carried out over a sufficient 
period of time and across sufficient locations 
to adjust for temporal and spatial variations in 
cycling or walking. 
2.2. Time needed to reach full level of 
walking or cycling
Transport interventions can take various 
lengths of time to influence a particular type 
of behaviour. For example, a certain new cycle 
path might result in immediate uptake, while it 
might take a year or more to see levels of use 
increase on another. Transport appraisals should 
allow for different assumptions about the speed 
or level of uptake of cycling or walking after such 
interventions.
2.3. Interactions between transport- 
related physical activity, air pollution 
and road traffic injuries
Transport-related health effects include possible 
negative effects from exposure to ambient 
air pollution or road traffic injuries. Possible 
interactions between the positive effects of 
exercise through active transport and such 
negative effects need to be considered. To date, 
no comprehensive review of active transport 
and physical activity is available that takes the 
possible negative effects of ambient air pollution 
into account.
Regarding road traffic injuries, evidence 
suggests that, if promotion of active travel is 
accompanied by suitable transport planning 
2 Methodological guidance on economic appraisal of health effects related to walking and cycling
6and safety measures, active commuters are likely 
to benefit from a “safety in numbers” effect (10): 
with increasing levels of active travel, walking 
and cycling become safer. Such measures could, 
at the same time, lead to less exposure to air 
pollution if more cycling occurs away from main 
roads.
Two recent scenario analyses showed that, in 
most cases, especially in western Europe, the 
positive health effects of cycling are likely to 
greatly outweigh the negative effects of air 
pollution and road traffic accidents suffered 
by cyclists (11,12). Also, the use of all-cause 
mortality estimates (see also below) rather 
than cause- specific ones has the advantage of 
incorporating the possible detrimental effects 
associated with walking or cycling. Nevertheless, 
developing modules to incorporate the health 
effects related to air pollution and injuries have 
been identified as items for further refining HEAT. 
2.4. Mortality or morbidity?
Physical activity has beneficial effects on many 
aspects of morbidity such as coronary heart 
disease, stroke, diabetes, some types of cancer, 
musculoskeletal health, energy balance and 
aspects of mental health (including anxiety and 
depression) and improving functional health in 
elderly people (13). From a public health point 
of view, these benefits materialize more rapidly 
than reductions in mortality. They can also be 
important in motivating individuals to walk and/ 
or cycle, as people may be more likely to increase 
their physical activity to improve their immediate 
health and well-being than to prolong their life. 
Nevertheless, the current evidence on morbidity, 
both for walking and for cycling, is more limited 
than that on mortality. Thus including the impact 
of morbidity in an economic appraisal leads to 
greater uncertainty. The consensus meetings 
therefore recommended, for the time being, 
focusing only on all-cause mortality for HEAT for 
walking and for cycling. It should be noted that 
this method is likely to produce conservative 
estimates, since it does not account for disease- 
related benefits.
Nevertheless, addressing morbidity was 
identified as another important item for later 
refinement to broaden the tool’s appeal (see 
also section 3.2).
2.5. The nature of the relationship 
between physical activity and health
Epidemiological studies report relationships 
between different categories or levels of 
exposure and health outcomes. For example, 
a comparison of sedentary people with people 
who are active beyond a specific threshold (such 
as 150 minutes of activity per week) may show 
that active people are healthier. However, there 
is a strong consensus that physical activity has 
a continuous dose–response relationship with 
most health outcomes, i.e. each increase in 
physical activity is associated with additional 
health benefits (13,14). This has also been shown 
by studies looking specifically at walking or 
cycling (15,16). 
To develop a method to quantify the health 
effects of active transport, a dose–response 
relationship needs to be incorporated. For many 
health outcomes, the exact shape of the curve 
is still uncertain (13) but, for mortality, literature 
suggests that the relationship is most likely 
non-linear (17–19). Meta-analyses on the risk 
of all-cause mortality and cycling and walking 
carried out as part of the HEAT updating process 
in 2013–2014 (20,21) supported this finding (see 
also section 3.2). However, they also showed that 
differences between various dose–response 
curves were small and that a linear function 
would represent a good fit of the data.
Based on this, the international advisory group 
concluded that, overall, a linear dose–response 
function is the most suitable one to use for 
7HEAT. In this way, users do not have to know 
the baseline level of physical activity of their 
subjects, and a constant absolute risk reduction 
can be applied for all HEAT applications within 
the range of exposure for which an incremental 
reduction of mortality risk can be observed (see 
Chapter 4). An approach based on a non-linear 
relationship could be adopted as part of future 
updates of HEAT, when suitable data on the 
baseline level of physical activity in different 
populations are available to provide default 
values for HEAT. 
In general, appraisals should consider the 
distribution of physical activity in the population 
in question. In particular, caution should 
be exercised in interpreting the results of 
modeling walking or cycling benefits in groups 
disproportionately comprising sedentary or 
very active individuals, as this could lead to 
a small overestimation of benefits in already 
active groups of the population and a small 
underestimation in less active ones.
There is some limited evidence of a stronger 
association between the perceived intensity 
(pace) of walking and health effects than for 
volume of walking (16,22). However, these 
studies did not correct for the fitness of the 
participants or the true distance covered 
and it remains difficult to assess their relative 
importance. In general, taking account of 
walking or cycling pace might lead to a more 
accurate assessment of the health effects, for 
example by differentiating between the different 
paces in leisure and transport walking or cycling, 
8but it will also lead to more complicated models 
and additional uncertainties. HEAT does not take 
into account differences in  the pace (or intensity) 
of walking or cycling, or the possibility that less 
well-trained individuals may benefit more and 
better-trained individuals may benefit less from 
the same amount of walking or cycling.
2.6. Age groups
Ideally, economic analysis would be able to take 
account of the differential effects of physical 
activity on children and adults, and on adults 
of different ages. However, the vast majority of 
epidemiological studies have been conducted 
on adults, mainly because the most commonly 
studied disease end-points such as coronary 
heart disease or death are rare in children, and 
studies on adults are easier to carry out. Thus the 
evidence base for the chronic health effects of 
physical activity on young people is not as large 
as that for adults. The advisory group concluded 
that the evidence for children and adolescents 
was insufficient, and that economic appraisals 
should focus on adults only in the first instance.
Studies find that risk reduction differs by age; for 
example, increased activity might yield higher 
benefits in older age groups than in younger 
age groups. Differentiating risk reduction by 
age groups could further enhance the results of 
economic appraisals. However, this would require 
cycling and walking data by age groups, which 
is so far usually not available. The availability of 
transport data by age group should be further 
improved. 
Age is also very relevant for the mortality rates 
used. Mortality rates vary substantially by age, 
and thus the choice of age range for the rate used 
in an economic appraisal can have a significant 
impact on the calculated benefits.
Therefore, the age groups to which the results 
may be applied and for which mortality rates 
were used should be made explicit. If any model 
is subsequently applied to children or older 
adults, any related assumptions should also be 
made explicit.
2.7. Sex
The review of the epidemiological evidence did 
not find obvious differences between the sexes 
in the effects on all-cause mortality (see section 
3.2) that would warrant different relative risk 
estimates for men and women.
Active transport behaviour can differ between 
men and women; for example, women often 
walk and cycle more than men. Ideally, economic 
analyses should take account of such gender 
differences.
2.8. Time needed for health benefits to 
build up
The epidemiological evidence on the effects on 
health of physical activity (13,14) implies that 
economic analysis should be carried out for 
habitual walking and cycling behaviour.
It is important to recognize that there will be a 
delay between increases in physical activity and 
measurable benefits to health. Based on the 
best available evidence, it was concluded that 
five years was a reasonable assumption to use for 
such “newly induced physical activity” to reach 
full effect, with an increment of 20% in benefits 
each year.
2.9. Activity substitution
This guidance is concerned with the effect on 
health of transport infrastructure and other types 
of transport interventions that are expected 
to result from walking or cycling. However, 
most of the literature on risk of disease relates 
to total physical activity, usually a composite 
index expressing overall energy expenditure 
(often measured as kilocalories (kcal) per week) 
or time spent active, including a wide range of 
9non-transport activity such as leisure-time and 
occupational activity. The approach therefore 
needs to address the issue of a potential 
substitution of one form of activity for another, 
which could occur in two ways.
1. Does an observed increase in rates of walk-
ing and cycling necessarily mean there has 
been an increase in total physical activity? 
For example, people may have stopped 
jogging when they started cycling or 
walking to work. While this is theoretically 
possible, none of the involved experts was 
aware of any evidence that would support 
such a pattern. Nevertheless, intervention 
studies should consider, for example, that 
a new cycle path may lead to a user’s new 
journey actually being shorter than before.
2. The results of studies on walking or cycling 
could be confounded by other forms of 
physical activity, such as leisure- time 
activities. This could lead to an overesti-
mation of the health effects of walking 
or cycling if those people who cycle or 
walk were actually more active through 
other forms of physical activity. It is rec-
ommended that activity substitution is 
accounted for in economic analyses as 
far as possible. This means not assuming 
that any increase in cycling or walking 
automatically leads to a similar increase 
in total physical activity, and using stud-
ies that correct for non-transport- related 
forms of physical activity. 
2.10. Seasonality and regional 
differences in cycling and walking
Cycling and walking behaviour may depend 
somewhat on location and culture, and climate 
and seasonality may also influence the total 
annual amount of walking and cycling. To date, 
very few published studies have explained 
how exposure was controlled for the effects 
of seasonality or climate (21). The available 
evidence does not yet enable a consolidated 
approach to be developed to address this issue. 
It is recommended to use local data on walking 
and cycling levels to take into account context-
specific effects of seasonality, culture or climate.
2.11. Static versus life tables approach
Since economic appraisals evaluate benefits 
over a period of time, several parameters may 
not stay constant over the time of the analysis. 
For example, the mortality rate in the population 
may change, owing to an increase in walking 
or cycling or other factors. The evaluated 
populations also represent a broad age range 
and health effects may vary by age. Life table 
calculations constitute a methodology to 
address these issues.
Recent scientific appraisals of health benefits 
from physical activity have applied such 
approaches. However, since introducing life-
table calculations in HEAT would increase the 
complexity for its target users and since the 
potential improvement in accuracy appears 
to be small compared with the remaining 
uncertainties in various other parameters of such 
appraisals,  the international advisory group 
concluded that life-table calculations should not 
be introduced in HEAT at this stage.
2.12. Costs applied
To conduct an economic appraisal of walking 
and cycling, it is necessary to agree on a method 
of valuing health (or life). There are a number of 
ways in which this can be done.
• A standard value of a statistical life (VSL)
This is often used in transport appraisals. It 
is most commonly derived using a method 
called willingness to pay. The willingness to 
pay shows how much a representative sample 
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of the population (who, in this instance, are 
potential victims) would be willing to pay (in 
monetary terms) for example for a policy that 
would reduce their annual risk of dying from 
3 in 10 000 to 2 in 10 000. 
• Cost of illness
This applies costs (for example costs to the 
national health service or loss of earnings) to 
each specific disease.
• Years of life lost (or gained)
This allows a more comprehensive assessment 
of health effects, as it takes the life expectancy 
of the participants into account.
• Quality-adjusted life-years
These are derived from years of life spent in 
ill health, multiplied by a weight measuring 
the relative undesirability of the illness state.
• Disability-adjusted life-years” (DALYs)
These measure the overall disease burden, 
expressed as the number of years lost due to 
ill health, disability or early death.
Different economic end-points are preferred by 
different audiences – transport planners often 
prefer VSL, while health experts prefer years of 
life lost or health care costs. As this project was 
aimed primarily at transport appraisals, the VSL 
approach was used, as this is more common in 
transport appraisals. 
A recent review has found an average VSL of 
US$ 3.6 million for the EU27 countries (23) (see 
also section 3.1). This is substantially higher 
than earlier commonly used values in Europe, 
such as the €1.5 million proposed by the UNITE 
study (24), which was previously used by HEAT 
(5). Thus, internationally, VSL differs substantially 
(23–25); it is therefore recommended to use 
either a current, internationally agreed VSL or a 
local VSL, where available.
Other methods, such as an approach based on 
QALYs, could be adopted if data were available to 
permit a more comprehensive assessment and 
to broaden the appeal for a health audience. 
However, this would be challenging given the 
difficulties of assessing the effects of walking and 
cycling on morbidity (see also section 2.4) and 
would require more substantial changes to the 
design of HEAT.
2.13. Discounting
Since benefits occurring in the future are 
generally considered less valuable than those 
occurring in the present, economists apply a so 
called “discount rate” to future benefits. In many 
cases, the economic appraisal of health effects 
related to walking and cycling will be included 
as one component into a more comprehensive 
cost–benefit analysis of transport interventions 
or infrastructure projects. The final result of 
the comprehensive assessment would then 
be discounted to allow a calculation of the net 
present value.
When the health effects are to be considered 
alone, it is important that the methodology 
allows for discounting to be applied to this result 
as well.
2.14. Sensitivity analysis
Carrying out economic appraisals of the health 
effects of transport behaviour is a complex 
undertaking and will invariably involve a number 
of assumptions and expert judgements, as 
outlined above.
It is strongly recommended that the uncertainties 
around an assessment are made explicit, and 
that the calculations are carried out with high 
and low estimates of the main variables in order 
to gain a better understanding of the possible 
range of the final results.
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3.1. Economic literature
To inform the development of the first version 
of HEAT for cycling, a systematic review of 
economic analyses of cycling and walking 
projects was carried out in 2007, in collaboration 
with the National Institute for Health and Care 
Excellence (NICE) in the United Kingdom (7,26). 
The review aimed:
• to identify relevant publications through 
expert consultation and tailored searches of 
the literature;
• to review the approaches taken to including 
health effects in economic analyses of trans-
port interventions and projects; and
• to propose recommendations for the further 
development of a harmonized methodology, 
based on the approaches developed to date.
To be included in this review, a study was 
required to:
• present the findings of an economic valua-
tion of an aspect of transport infrastructure 
or policy;
• include data on walking and/or cycling in the 
valuation;
• include health effects related to physical 
activity in the economic valuation; and
• be in the public domain.
A total of 16 papers were included from an 
original list of 4267 titles. These covered a range 
of approaches to economic analysis, the majority 
being cost–benefit analyses of cycling projects 
or programmes. Quality was variable: using the 
quality scale adopted by NICE, only three of the 
studies were classified as “high quality” with a 
high probability that the observed relationship 
is causal (2++), six as “well conducted” with a 
moderate probability that the relationship is 
causal (2+) and seven “low quality” (2–).
Generally, the economic analyses showed 
positive benefit–cost ratios, the median being 
5:1 with a range from –0.4 to 32.5. However, 
owing to the different methods applied in the 
studies, this value has to be viewed with caution. 
Some studies estimated the value attributed to 
each new walker or cyclist; these ranged from 
about €120 to €1300.
3 Reviews of the literature: summary
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The review found wide variation in the 
approaches taken to including health effects 
of physical activity in economic analyses of 
transport projects. This was not helped by a lack 
of transparency in the methods used in many of 
the studies reviewed. The studies used various 
sources of data as the basis for their calculations, 
there appeared to be no consensus on the 
diseases to be included in mortality calculations, 
and few studies included a measure of morbidity.
One of the most significant challenges identified 
was the relationship between observed cycling 
or walking and total physical activity. Studies 
had to: use modeling to make assumptions 
about how cycling or walking might influence 
total physical activity; assume that all observed 
cyclists or walkers could be classed as sufficiently 
active (and therefore had a reduced risk and/ 
or reduced medical costs); or make some sort 
of estimate of the scale of benefit somewhere 
between these two extremes. One study used 
an approach based on the relative risk of all- 
cause mortality among cyclists compared to 
non-cyclists. It appeared to have the greatest 
potential for further development towards a 
more uniform approach. This methodology was 
proposed as the basis for the development of the 
first version of HEAT for cycling (4).
As part of the work on developing HEAT for 
walking and updating HEAT for cycling in 2010, 
an update was carried out of this systematic 
review designed to find papers published on the 
same topic since 2006 (27). The same protocol 
was used for this search. Of over 1800 hits, 8 
publications met the inclusion criteria.
The studies included in this review indicated that 
there did not appear to have been a significant 
methodological advance in valuing the health 
benefits of active travel. Methods remained 
variable, with limited transparency and 
reliance on numerous assumptions. As noted 
in the previous review, in most cases the health 
benefits of cycling and walking were based on 
the literature on physical activity in general, 
requiring assumptions on the health effects of 
cycling and walking being equivalent to other 
forms of physical activity as well as regarding the 
absence of “activity substitution”.
Although excluded from the review on technical 
grounds for not including an economic 
assessment, the approach by Woodcock et al. 
(28) appeared to be the most systematic and 
methodologically robust. The core group was 
also made aware of studies in progress that 
used approaches involving QALYs or DALYs. 
While these approaches have many inherent 
advantages, the primary target audience for 
the HEAT for walking is transport planners (see 
also sections 2.12 and 4.2) and they are familiar 
with calculations based on VSL. Studies based on 
metrics used predominantly in the health sector, 
such as DALYs, are not directly applicable to this 
target audience.
It was concluded that the literature review 
supported developing a HEAT for walking using 
a similar approach as for the HEAT for cycling: 
estimating the value of reduced risk among 
walkers based on VSL. The 2013 consensus 
meeting also confirmed this general approach. 
As explained in section 2.12, HEAT uses the VSL 
method to economically quantify the health 
benefits of reduced mortality from walking or 
cycling. Due to the dearth of official VSL studies, 
HEAT previously suggested using either a default 
value of €1.574 million (5,24) or a national VSL. 
The Organisation for Economic Co-operation 
and Development (OECD) recently published 
a comprehensive review of VSL studies (23). 
Studies were only included if they were based 
on a representative population sample of at least 
200 subjects (or 100 for subsamples of larger 
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studies) and provided information on the size 
of the risk change in question. About 400 values 
were selected to calculate the VSL for adults in 
38 countries around the world. For the EU27 
countries, an average VSL of US$ 3.6 million with 
a range from US$ 1.8 million to US$ 5.4 million 
(2005 US dollars). 
Although the international advisory group 
acknowledged that other projects were 
underway aiming at developing a European VSL, 
it concluded that the OECD report represented 
the best currently available evidence. The 
international advisory group recommended 
using an updated European VSL, based on the 
OECD method. In addition to the EU27 value, a 
new European average value as well as country-
specific default values will be provided (see 
sections 5.2 and 6.2). 
3.2. Epidemiological literature
3.2.1. Cycling
The strongest evidence at the time of the 
first project on the health effects of cycling 
was the relative risk data from two combined 
Copenhagen cohort studies (29). This study 
included 6954 20–60-year-old participants, 
followed up for average of 14½ years. It found a 
relative risk of all-cause mortality among regular 
commuter cyclists of 0.72 (95% confidence 
interval (CI): 0.57–0.91) compared to non-cycling 
commuters, for 3 hours of commuter cycling per 
week. It controlled for the usual socioeconomic 
variables (age, sex, smoking, etc.) as well as for 
leisure- time physical activity. As recommended 
(3,7), it also adjusted for the possibility that 
observed associations between commuter 
cycling and mortality might have been caused 
(or inflated) by higher levels in leisure-time 
activity among cyclists.
In 2010, the evidence with regard to cycling was 
reassessed and, again, it was not possible to carry 
out a meta-analysis as there were insufficient 
relevant studies on cycling. A systematic review 
by Oja et al. (15) found only three prospective 
population studies on cycling and all-cause 
mortality. 
In 2013, a new systematic review on the reduced 
relative risk of all-cause mortality from regular 
cycling was carried out (20). 
To be included in this review, a study was 
required:
• to be a prospective cohort study; 
• to report the level of regular walking or 
cycling (such as duration, distance or MET 
equivalent); 
• report all-cause mortality rates or risk reduc-
tions as outcome; and
• report results independent of (that is, adjusted 
for) other physical activity. 
A total of 8901 titles were identified, and 431 full 
texts were screened. Seven cycling studies met 
the inclusion criteria. Based on the Newcastle-
Ottawa quality assessment scale for cohort 
studies, the studies were generally of high quality, 
scoring between 6 to 9 of 9 possible points. A 
meta-analysis was carried out, combining the 
results of these seven studies (20). 
Since the available studies used a range of 
different exposures, to conduct the meta-
analysis it was necessary to estimate for each 
study the reduced risk at a common exposure 
level. For this purpose, the different cycling 
exposures used in the studies were converted 
into MET-hours per week (assuming a linear dose-
response relationship and an average intensity 
of 6.8 METs for cycling if not otherwise stated). 
The common exposure level was set at 11.25 
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MET-hours per week. This value was derived from 
the global physical activity recommendations 
as corresponding to the recommended level 
of at least 150 minutes of moderate-intensity 
physical activity per week (14) using 4.5 METs 
as an average for moderate-intensity physical 
activity. Using 6.8 METs as an average intensity 
for cycling, this exposure represents about 100 
minutes of cycling per week. 
The sensitivity of the results to various possible 
shapes of dose–response relationships 
was tested. As explained in section 2.5, the 
differences between the various curves were 
small and the difference in the final risk estimate 
was no more than 6%. The international advisory 
group recommended that, for HEAT, a linear 
dose–response curve based on a relative risk 
of 0.90 (CI 0.87–0.94) for cycling and applying 
a constant absolute risk reduction would be the 
most suitable approach given its good fitting of 
the data and the simplicity of implementing it 
in HEAT.
3.2.2. Walking
In 2010, a systematic review to  derive a risk 
estimate to be used for HEAT for walking was 
carried out (5,27). The review found nine studies 
meeting the inclusion criteria. These studies 
were combined in a pooled-analysis to calculate 
an aggregated risk, weighted by sample size. The 
resulting relative risk estimate was 0.78 (95% CI: 
0.64–0.98) for a walking exposure of 29 minutes, 
7 days a week,  which was used for the first HEAT 
walking. 
In 2013, an updated systematic review and 
meta-analysis for walking was carried out 
similar to the one on cycling described in the 
previous section. Fourteen studies on walking 
and all-cause mortality met the inclusion criteria, 
also yielding high quality scores of 7 to 9 out 
of 9 possible points on the Newcastle-Ottawa 
Quality assessment scale for cohort studies. 
As for cycling, a meta-analysis was carried out, 
converting the different walking exposures into 
a common metric and using 11.25 MET-hours 
per week as common reference level for the 
risk reductions. Using an average intensity 4.0 
METs for walking, this exposure represents 168 
minutes of walking per week. Depending on the 
shape of the dose–response curve used, a risk 
reduction of 10–11% was found. 
For the HEAT walking, the advisory group also 
recommended using a linear dose–response 
curve based on a relative risk of 0.89 (CI 
0.83–0.96).
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The principles and guidance set out in Chapter 
2 have been developed into a practical tool for 
walking and for cycling, known as HEAT (6). The 
tool estimates the maximum and the mean 
annual benefit in terms of reduced mortality as 
a result of walking or cycling. It can be applied 
in a number of situations, as further described in 
section 4.4, such as:
• when planning a new piece of cycling or walk-
ing infrastructure, helping to make the case 
for investment;
• to value the reduced mortality from past and/
or current levels of cycling or walking; or
• to provide input into more comprehensive 
economic appraisal exercises or prospective 
health impact assessments.
It will help to answer the following question:
If x people cycle or walk for y minutes on 
most days, what is the economic value of 
the health benefits that occur as a result 
of the reduction in mortality due to their 
physical activity?
4.1. General principles of the tool
The following core principles for the HEAT tool 
were agreed upon by the international advisory 
groups. The tool should be:
• robust and based on the best available 
evidence;
• fully transparent regarding assumptions;
• based in general on a conservative approach
• (low-end estimates and default values); and
• as user-friendly as possible.
4.2. Who is the tool for?
The tool is based on the best available evidence 
and transparent assumptions. It is intended to be 
simple to use by a wide variety of professionals 
at both national and local levels. These include 
primarily:
• transport planners;
• traffic engineers; and
• special interest groups working on transport, 
walking, cycling or the environment.
4 The HEAT for walking and for cycling: introduction
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The tool is also of interest to health economists, 
physical activity experts or health promotion 
experts. However, due to the use of transport- 
specific methods such as VSL, the results of HEAT 
in its current form might need to be accompanied 
with additional information and explanations for 
such audiences.
4.3. What can the tool be used for?
The tool can be used in a number of different 
situations.
• It can be used when planning a new piece 
of cycling or walking infrastructure. HEAT 
attaches a value to the estimated level of 
cycling or walking when the new infrastruc-
ture is in place. This can be compared to the 
costs of implementing different interventions 
to produce a cost–benefit ratio (and help to 
identify the most cost-effective investment).
• It can be used to evaluate the reduced mortal-
ity from past and/or current levels of cycling 
or walking, such as to a specific workplace, 
across a city or in a country. It can also be used 
to illustrate the economic consequences of a 
potential future change in levels of cycling or 
walking.
• It can be used to provide input to more com-
prehensive economic appraisal exercises, 
or prospective health impact assessments, 
such as to estimate the mortality benefits 
from achieving targets to increase cycling or 
walking or from the results of an intervention 
project.
The tool provides an estimate of the economic 
benefits accruing from walking or cycling 
as a result of lower death rates. Ideally, for 
a comprehensive assessment, it would be 
supplemented with data on other potential health 
outcomes from walking or cycling (morbidity) 
and combined with other transport-related 
outcomes such as less congestion, reduced 
journey times or fewer road traffic injuries. These 
and other enhancements will be considered for 
inclusion in future versions of the tool.
4.4. What should the tool not be used 
for?
Before using HEAT, the following should be 
considered carefully to make sure HEAT is 
applicable.
1. HEAT is to be used for assessments at the 
population level: for groups of people  and 
not for individuals.
2. The tool is designed for habitual walk-
ing or cycling behaviour, such as for 
commuting or regular leisure-time 
activities. In particular, it should not 
be used for the evaluation of one-day 
events or competitions (such as walking 
days), since these are unlikely to reflect 
long-term average activity behaviour. 
 
In addition, HEAT for walking is meant to 
be applied for walking of at least moderate 
pace, i.e. about 3 miles/hour (4.8 km/hour), 
which is the walking speed of the studies 
in the meta-analysis, where available. 
This is also consistent with the minimum 
walking pace necessary to require a level 
of energy expenditure considered to bring 
health benefits (13); for cycling, this level 
is usually achieved even at low speed. If 
the walking pace in the study population 
is unknown, HEAT will assume that it is 4.8 
km per hour.
3. HEAT is designed for adult populations.
For HEAT for cycling, the recommended 
applicable age range is approximately 
20–64 years and for HEAT for walking, 
approximately 20–74 years (see also sec-
tion 4.5). HEAT should not be applied to 
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populations of children, very young adults 
or older people since the available evidence 
was not sufficient to derive a relative risk for 
these age groups (see also section 2.6).
4. HEAT should not be used in populations 
with high average levels of physical activity.
Studies on the benefits of physical activity 
for decreasing premature mortality have 
typically been conducted in the general 
population, where very high average 
levels of physical activity are uncommon. 
The exact shape of the dose–response 
curve is uncertain, but it seems to level off 
above physical activity levels that are the 
equivalent of about 1 hour of brisk walking 
or cycling per day. Therefore, the tool is not 
suitable for populations with high average 
levels of walking or cycling (such as profes-
sional athletes, postal delivery workers or 
bicycle couriers) that exceed the activity 
levels common in an average adult popula-
tion. Caution also has to be applied when 
using the tool in predominantly sedentary 
populations, since the underlying risk esti-
mates were derived from populations with 
a broad distribution of activity levels. HEAT 
could therefore slightly underestimate the 
effect in very sedentary population groups.
5. The accuracy of the HEAT calculations 
should be understood as estimates of the 
order of magnitude of the expected effect 
rather than as precise estimates. 
Knowledge of the health effects of walking 
and cycling is evolving rapidly. These projects 
represent first important steps towards agreed 
harmonized methods. In developing these tools, 
on several occasions the international advisory 
group made expert judgements based on the best 
available information and evidence. Users should 
bear in mind the approximate nature of the results, 
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much like for many other economic assessments of 
health effects. Further improvements will be made 
as new knowledge becomes available. 
4.5. Basic functioning of the tool
Assessments can be carried out with two main 
types of data: (a) data from a single point in time; 
and (b) before and after data.
The former option is used when assessing the 
status quo, such as evaluating current levels 
of walking and cycling in a city. The latter is 
used when assessing the impact of an actual 
intervention or hypothetical scenarios; before 
and after data are required and the tool evaluates 
the difference in levels of walking and cycling 
between the two.
The tool is based on relative risk data from 
published studies (see section 3.2). As 
recommended (3,7), the included studies 
controlled for leisure-time physical activity as well 
as the usual socioeconomic variables (age, sex, 
smoking, etc.). This means that the relative risks 
reported for walking or cycling and mortality were 
independent of other forms of physical activity.
The tool uses these relative risks and applies them 
to the amount of walking or cycling entered by 
the user, assuming a linear relationship between 
walking or cycling and mortality. To illustrate this, 
the relative risk from the meta-analysis used for 
the updated version of HEAT for cycling is 0.90 
for regular commuter cycling for 100 minutes per 
week for 52 weeks of the year (equivalent to 87 
hours of cycling per year) (see also section 3.2). 
Thus, in any given year, regular cyclists receive a 
protective benefit of 10% (1.00 minus 0.90) – that 
is, they are 10% less likely to die from any cause 
than non-cyclists. If the user enters a cycling 
volume equivalent to 29 hours per year (i.e. three 
times less), the protective benefit of this amount 
of cycling will be roughly 3%. If the user enters 
174 hours (twice the time cycled in the reference 
population), the resulting protective benefit is 
20%. This is twice the protective benefit of the 
reference population.
To avoid inflated values at the upper end of 
the range, the risk reduction available from the 
HEAT is capped.  Inspection of the data points 
of the new meta-analyses suggested that, after 
about 45% risk reduction for cycling and 30% 
for walking, no significant further risk reductions 
were achieved. These limits were also confirmed 
by a large cohort study found through purposive 
review (18). On this basis, the advisory group 
recommended using these caps in the updated 
HEAT. Thus, HEAT will apply a maximum  45% 
risk reduction in the risk of mortality for cycling 
(corresponding to 450 minutes per week) and a 
maximum 30% risk reduction (corresponding to 
458 minutes per week) for walking.
HEAT then uses population-level mortality data 
to estimate the number of adults who would 
normally be expected to die in any given year 
in the target population. Next, it calculates the 
reduction in expected deaths in this population 
that cycle or walk at the level specified by the 
user, using the adjusted relative risk. Finally, the 
tool produces an estimate of economic savings 
Mode Applicable age range Relative risk Volume Benefits capped at
Walking 20-74 years 0.89 (CI 0.83–0.96) 168 minutes/week 30% (458 minutes)
Cycling 20-64 years 0.90 (CI 0.87–0.94) 100 minutes/week 45% (450 minutes)
CI: confidence interval.
Summary of basic values used for HEAT
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from this calculated reduction in deaths, as well 
as discounted and average savings.
The basic functioning of the tool is shown in fig. 1.
4.5.1. Applicable age range
HEAT for cycling is designed for analyses of 
adult populations aged about 20–65 years. This 
is because HEAT should be used for regular 
behaviour such as commuting, and the retirement 
age is about 65 years in most countries. After 
retirement, physical activity behaviour (especially 
that related to commuting) often changes. In 
addition, many mortality databases give mortality 
rates for up to 64-year-olds. For HEAT for walking, 
the  international advisory group recommended 
that this relative risk be applicable for an age 
range of approximately 20–74 years, as walking 
behaviour seems to be more sustained than 
cycling. These earlier conclusions were confirmed 
by the 2013 consensus meeting.
If the age distribution in the assessed population 
is significantly different (much younger, much 
older), HEAT may underestimate or overestimate 
the resulting benefits. In such cases, it is important 
to adjust the mortality rate used, which depends 
strongly on the age of the assessed population. 
However, HEAT should not be applied to 
populations of children, very young adults or 
older people, since the available evidence was 
not sufficient to derive a relative risk, especially 
for younger age groups, and the mortality rates 
would differ significantly for older age groups (see 
also sections 2.6 and 3.2).
4.6. What input data are needed?
To use HEAT, the following data are needed:
• an estimate of how many people are walking 
or cycling, which might come from route user 
surveys, population surveys or roadside counts, 
or could be estimates from scenario analyses 
(for more information on the use of surveys, 
see section 4.7); and
• an estimate of the average time spent walking 
or cycling in the study population, which can 
again come from surveys or estimates and can 
be entered in a number of ways:
•  duration (average time walked or cycled per 
person, e.g. 30 minutes walked on average 
per day), which is the most direct data entry 
route;
•  distance (average distance walked or cycled 
per person, e.g. 10 km cycled on average per 
day);
•  trips (average per person or total observed 
across a population, e.g. 250 bicycle trips 
per year); or
•  steps (average number of steps taken per 
person, e.g. 9000 steps per day).
A number of default values are provided in HEAT; 
these have been derived from the literature and 
agreed on as part of the expert consensus process. 
They should be used unless more relevant data 
are available that more accurately reflect the 
situation under study, for the following variables:
• mortality rate (a European average can be used 
or a national rate from the WHO European 
Detailed Mortality Database (30) for an average 
population (about 20–74 years old), a younger 
average population (about 20–45 years old) 
or a predominantly older average population 
(about 46–74 years old), or the local mortality 
rate can be entered);
• VSL (values commonly used across Europe are 
provided in the model but users may adapt this 
value by, for example, adopting agreed values 
for their own country; for more information see 
section 2.12);
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Volume of walking/cycling per person
duration/distance/trips/steps 
(entered by user)
Population that stands to benefit  
(entered by user or calculated 
from return journeys)
General parameters 
Intervention effect, build-up period, mortality 
rate, time frame (changeable default values)
Estimate of economic savings 
using VSL
(changeable default value)
Protective benefit (reduction in mortality as a result of walking/cycling) = 
Volume of walking/cycling
Reference volume of walking/cycling††(1 – RR
†) *
Fig. 1. Basic functioning of HEAT
†RR = relative risk of death in 
underlying studies (walking: 
0.89 and cycling: 0.90 (20)). 
††Volume of cycling per 
person calculated based 
on 100 minutes  per week 
for 52 weeks per year at an 
estimated speed of 14 km/
hour. Volume of walking 
based on 168 minutes per 
week at 4.8 km/hour.
• the period of time over which average benefits 
are to be calculated; and
• a discount rate, if so wished (see also section 
2.13); the default value supplied can be used 
or an alternative rate can be entered.
In addition, details of the cost of promoting 
cycling or walking can be entered, which can be 
used to calculate a benefit–cost ratio. 
Along the way, some assumptions may need to 
be taken where no data are available, such as 
on the supposed impact of an intervention on 
newly induced levels of walking and cycling. 
Input is provided for such assumptions, wherever 
possible with default values (and their sources). 
Explanations and further information on the 
different steps of the tool as well as a section 
with frequently asked questions are provided 
on the web site  (see also Chapters 5 and 6).
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4.7. Data sources
Input data for the model may come from a 
number of sources, including:
• route user surveys;
• population-level travel behaviour surveys;
• destination-based behaviour travel surveys 
(e.g. commuter behaviour); and
• traffic counts.
Alternatively, informed estimates may serve as 
surrogates for empirical data, such as in scenario 
calculations. In all cases, it is important to use the 
most reliable data possible and to validate these 
with secondary sources where available.
Ultimately, the quality of economic appraisals will 
depend entirely on the accuracy of the walking 
and cycling data used. A few considerations will 
help to make the best use of the available data 
and avoid mistakes.
4.7.1. Use of short-term counts and surveys 
The main concern with short-term counts is 
that they do not accurately capture variations in 
walking or cycling over time (i.e. time of the day, 
day of the week, season or weather). If counts are 
done on a sunny day, larger numbers may be seen 
than on a rainy day. Cycling also typically declines 
in the winter months compared with spring and 
summer in many countries. Since HEAT assumes 
that the entered data reflect long-term average 
levels of walking or cycling, data from short-term 
counts may distort the results.
This issue will affect single-site evaluations (such 
as a footpath or a bridge) where counts are 
conducted at the site itself, or community- wide 
evaluations that are based on surveys conducted 
only during a certain time of the year.
Short-term counts may also be adjusted for 
temporal variation to better reflect long-term 
levels of walking or cycling. An example for how 
this can be done is provided by the national 
bicycle and pedestrian documentation project in 
the United States (31).
Not affected by this issue are assessments based 
on large surveys conducted on a rolling basis, 
such as national travel surveys, or automated 
continuous counts.
4.7.2. Use of data from a few locations 
Spatial variation, particularly in walking, may 
affect evaluations that are based on counts at a 
single or a few locations. The choice of location 
may strongly influence the count numbers, 
which may not be representative of the wider 
level of walking (or cycling). Results need to be 
interpreted carefully, and should in general not be 
extrapolated beyond the locations where actual 
data were collected.
Not affected by this issue are evaluations based 
on surveys that sample subjects randomly from 
a defined area (such as large household surveys) 
and, to a lesser extent, count-based evaluations 
on linear facilities such as trails.
4.7.3. Use of trip or count data
In HEAT, trip or count data need to be combined 
with an estimate of average trip length in order 
to calculate the volume of walking or cycling. 
An example is provided by counts conducted 
on a bridge, where it remains unknown how far 
people walk or cycle beyond the bridge. Average 
trip distance estimates may be derived from user 
surveys on a specific facility or from travel surveys.
There are several methods of estimating cycling 
and walking distances.
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• Cyclists or pedestrians can be asked to draw 
their route on a map and to measure the 
distance (32,33).
• Cyclists and pedestrians can be asked to pro-
vide their starting and finishing points and to 
multiply the straight-line distance between the 
two points with a correction factor. One study 
has suggested a factor of 1.26 (33).
• Another method is based on subjective 
estimates of distance travelled, although this 
has been shown to lead to distances being 
overestimated and not to be always reliable 
(33). Thus, if subjective measures are used, it is 
recommended that a correction be made for 
overestimation; a correction factor of 0.88 has 
been suggested (33).
• Making use of global positioning systems (GPS) 
has been shown to overestimate the distance; 
a correction factor of 0.95 has therefore been 
suggested (33).
• Making use of shortest- or fastest-route 
algorithms in geographical information 
systems has been shown to overestimate 
distance by between 12% and 21%, depending 
on  the algorithm  used (33). This corresponds to 
correction factors of 0.89 and 0.83, respectively.
4.7.4. Use of pedometer data 
If assessments are based on pedometer data, it 
should be ensured that the number of steps used 
is predominantly composed of intentional brisk 
walking. Some pedometers have a function that 
excludes steps that are not deliberate walking.. 
Another approach could be to include only 
intentional walking steps at a rate of about 100 
steps per minute (34) or to make an assumption 
of the proportion of total steps falling into this 
category. 
4.8. What data will the tool produce?
The tool will produce an estimate of the following 
outputs:
• maximum annual benefit;
• mean annual benefit; and
• net present value of mean annual benefit. 
The maximum annual benefit is the total value 
of reduced mortality due to the level of walking 
or cycling entered by the user. This is a maximum 
value, as it assumes that the maximum possible 
benefits to health will have occurred as a result of 
the entered level of walking or cycling. In reality, 
the health benefits are likely to accrue over time.
The mean annual benefit is therefore the key 
output of the model. It adjusts the maximum 
annual benefit (total value of lives saved due to 
the level of walking or cycling entered by the 
user) by three main factors:
• an estimate of the time it takes for the health 
benefits from regular walking or cycling to 
occur;
• a build-up period for uptake of walking or 
cycling, which allows the user to vary the 
projections in uptake if valuing a specific 
intervention such as for a new cycle path, and 
varies for full usage occurring between 1 and 
50 years; and
• the net present value of mean annual benefit, 
which adjusts the above outputs to take the 
diminishing value of current savings over time 
into account (the model suggests a discount 
rate of 5% but this can be varied).
 
2 The default value used in HEAT is five years, based on expert 
consensus achieved with the international advisory group. As this 
period is based on the physiological mechanism of physical activity 
behaviour with an impact on health, it cannot be changed by the user.
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5.1. How to access the tool
The tool is available on the WHO Regional 
Office for Europe web site at www.euro.who.
int/HEAT (6) or directly from the HEAT site www.
heatwalkingcycling.org
5.2. How to use the tool: five simple steps
5.2.1. General features of the HEAT web site 
HEAT is composed of 16 questions in total; 
depending on the route taken, some questions 
will be skipped. On the left-hand side of the screen, 
the flow chart of questions helps users to orientate 
where they are in the assessment process.
Click on “next question” or “back” to move 
between questions; do not use the back-button 
of your internet browser. You can also go back to a 
previous question by clicking on it in the flow chart 
of questions on the left-hand side of the screen. If 
you make changes, click on “save changes” before 
you continue.
On all HEAT screens, by hovering with the mouse 
over an entry option, the relevant “hints and tips” 
box or boxes will be highlighted on the right- hand 
side of your screen.
There is also a section with frequently asked 
questions, where further hints and tips can be 
found. 
Step 1: entering walking data
First of all, the scope of the use of HEAT needs to 
be considered to make sure that it is applicable for 
an assessment (see also section 4.1).
If HEAT is right for the study in question, a decision 
needs to be taken as to which of the two possible 
data types is going to be used for the assessment.
• Data from a single point in time are used 
when assessing the status quo, such as valuing 
current levels of walking in a city, or if data on 
the results of an intervention only are available 
(no “before” data).
• Before and after data are used when assessing 
the impact of an actual intervention or 
hypothetical scenarios. Before and after data are 
required, and the tool evaluates the difference 
in levels of walking between the two.
All assessments require two main parameters to 
be entered:
1. the amount of walking done in the study 
area as duration (the most direct entry 
route), distance, trips or steps (more 
information on data sources is given in 
section 4.7); and
5 HEAT for walking:  instructions for users
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2. the number of people benefiting from this 
amount of walking.
Amount of walking: select the desired option for 
input data
The amount of walking can be entered per day, 
week, month or year as follows.
Duration
Enter the average time spent walking per person.
Distance
Enter the average distance walked per person.
Trips
If data are entered as trips, the average number 
of trips per person can be entered or the total 
number of trips observed in the study area (e.g. 
from a count of pedestrians passing a sample 
point). If the total number of trips includes trips by 
modes of transport other than walking, the mode 
share option can be used to take account of this 
by specifying the proportion of these trips that are 
walking trips.
Then, either the total number of people taking 
these walking trips or the proportion of these 
trips that are return journeys needs to be entered. 
For example, if 1000 trips a day are observed 
at a sample point, this could correspond to 
1000 individuals each counted once or 500 
individuals each counted twice (as they make a 
return journey), or some combination of the two. 
Whenever possible, it is strongly recommended 
to use the actual number of people walking. 
This is because alternative methods involve a 
number of assumptions, which would reduce 
the accuracy of the results. If the total number of 
people taking these trips is unknown, the tool will 
use the proportion of return journeys to estimate 
the number of individuals taking the trips. As 
the HEAT website assumes that the trip data you 
have entered relates to a regular (i.e. daily or near-
daily) pattern of walking, the number of individual 
walkers is calculated from the proportion of return 
journeys, using the daily average number of trips. 
On the HEAT for walking web site, input is given to 
derive the best proportion of return journeys for 
different types of count data.
Finally, the duration or distance of the walking 
trips has to be entered.
Steps
The average number of steps walked per person 
per day, week, month or year and the average 
step length can be entered. Otherwise, the default 
value of 71.5 cm (28.15 inches) can be used, which 
is the average of values often used for men and 
for women.
If data from a single point in time are assessed, 
the user can then enter the general parameters. 
Otherwise, users will be asked to enter the after-
intervention data. They can choose to use a 
different metric for the after data (e.g. duration 
for the before data and distance for the after data).
Number of people benefiting
The tool requires information on the number of 
individuals doing the amount of walking entered 
in the previous questions.
In many cases, this figure will be the number of 
walkers in the study area, city or country, or the 
number of people who stand to benefit from the 
reported levels of walking entered if the data were 
entered as walking trips (see above).
In some cases, walking data may have been derived 
from a survey based on a representative sample of 
a larger population, where the findings apply to 
the whole population. For example, in the case of 
a national travel survey that is representative of 
the whole population, the total population should 
be used rather than the sample size of the travel 
survey.
25
It is important to ensure that the correct population 
figure is entered, as this can substantially affect the 
resulting calculations.
Step 2: checking the walking summary
HEAT will now show a summary of the entries, 
allowing you to make corrections or to change 
entries. HEAT will also show the likely reduction in 
the risk of mortality in the study population, based 
on the entries (see also section 4.5).
Warning messages will appear here in two cases: 
(a) if levels of walking have been entered that are 
above the suggested scope of HEAT of about 1 
hour of brisk walking; and (b) if levels of walking 
have been entered that would theoretically lead to 
very high reductions in the mortality rate.
Specifically, if an equivalent of 120 minutes or more 
of walking per day is entered, users are requested 
to consider whether their entered volume of 
walking truly represents long-term behaviour in 
an average adult population, as this is what HEAT is 
designed for (see also section 4.4). To avoid inflated 
values, the risk reduction available from the HEAT 
walking is capped at 30% (see also section 4.5).
Step 3: impact of an intervention or all current 
walking?
In this step, users can decide whether they want 
to quantify the benefits of a current situation (or 
a scenario analysis) in a country, in a community 
or on a specific infrastructure. This means that 
HEAT will provide an estimate of the value of all 
the walking data entered (and no build-up period 
for the health benefits to accrue will be applied, 
see also section 4.8).
If instead  “impact of an intervention” is selected, 
the tool will ask for an estimate of the proportion 
of the walking that can be attributed to the 
intervention. When assessing the impact of an 
intervention, it is prudent to assume that not all 
the walking or increase in walking observed is 
newly induced.
Data to estimate the proportion of newly 
induced walking are rarely available. Therefore, 
the proportion of walking to be attributed to the 
intervention (i.e. to be evaluated) needs to be 
estimated to the best of the user’s knowledge. 
For guidance on this estimation, see the “hints and 
tips” box on this page.
It is strongly advised to calculate various scenarios 
with higher and lower percentages, as this number 
significantly affects the results.
Note that if users wish to assess the value of an 
increase in walking over time without a particular 
intervention, 100% should be entered.
Time needed to reach full level of walking
This allows adjustment for the estimated time it 
will take to reach the full level of walking entered. 
This can be particularly useful when assessing 
interventions. For example, if a new footpath 
is built and it is estimated it will take 5 years for 
usage to reach a steady state, this figure should 
be changed to 5. The default value has been set 
at 1 year.
Step 4: checking the parameters
The parameters in step 4 have been set by the 
expert advisory group according to the best 
information currently available. They should be 
changed only if reliable local data are available, as 
changes to these parameters can have a significant 
impact on the final values. Nevertheless, local 
values for the following two parameters should 
be used where available:
• For the value of a statistical life (in local currency), 
the standard value of a statistical life used 
in the country of study should be entered; 
the preferred currency can be chosen. This 
will form the basis of the cost savings in the 
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model. Whenever possible, enter a country-
specific value or use a country value from the 
drop-down menu (not available for Andorra, 
Monaco and San Marino). If this is not known, 
European default values of €2.487 million 
(WHO European Region), €3.387 million (EU-27 
countries) or €3.371 million (EU-28 countries 
including Croatia) can be used (see section 
2.12). These are based on a study by the OECD 
(23) that calculated an average VSL of US$ 3.6 
million for the EU-27 countries for 2005. This 
value was adjusted for income level differences 
across countries, inflation and income growth 
over time and conversion of the currency 
from USD to local currency, using purchasing 
power parity–adjusted exchange rates (35). 
Regional default values were derived using the 
population-weighted average of the country-
specific VSL estimates. 
• The annual rate of the working-age population 
that dies each year (deaths per 100 000 people 
per year in the respective age group) can be 
derived from published mortality data for 
people of working age for the study country. The 
default value is set at the last available average 
for the WHO European Region according to the 
WHO European Detailed Mortality Database 
(30). HEAT also provides national values as 
available in the WHO European Detailed 
Mortality Database (30). Users have the option 
to select default mortality rates for an average 
population (about 20–74 years old), a younger 
average population (about 20–45 years old) 
or a predominantly older average population 
(about 46–74 years old). It is suggested that 
the most recently available local rate be used 
wherever possible.
Users can also enter their own value. In this case, 
it is suggested to use the local crude annual 
death rate, as it reflects the age- and sex-specific 
mortality rates and the age and sex distribution 
of the population. Enter the number of deaths 
per year per 100 000 people aged 20–74 years. 
This allows the tool to focus on the age groups 
most likely to walk and reflects the relative risk 
of all-cause mortality in that age group (see also 
sections 3.2 and 4.5). If the age distribution in the 
assessed population is significantly different (much 
younger or much older), HEAT may overestimate 
or underestimate the resulting benefits. In such 
cases, it is important to adjust the age range of 
the mortality rate used. It must be noted, however, 
that HEAT is not appropriate for populations 
consisting mainly of children, very young adults or 
older people, as the underlying relative risk would 
not be appropriate.
The time frame for calculating mean annual 
benefit is the period over which the discounted 
mean annual benefit will be calculated. This is 
usually standardized within each country; the 
default value has been set at 10 years.
If it is known how much it costs to promote 
walking in a particular case (such as a specific 
promotion project or new infrastructure), and the 
user would like the tool to calculate a benefit–cost 
ratio for the local data, costs can be entered here. 
It needs to be made sure that the costs include all 
relevant investments. For example, to assess the 
benefit–cost ratio of a promotion campaign for 
walking, costs for the walking infrastructure used 
by the target audience, which may be borne by the 
local administration, will also need to be included. 
The time frame entered to calculate the benefit-
cost ratio can differ from the time frame entered to 
calculate the average annual benefit (see above).
For the discount rate, the rate to be used for 
calculating future benefits can be entered. Savings 
that occur in future years will be discounted by 
this percentage per year, and will be shown in the 
“present value” section of step 5. A rate of 5% has 
been set as the default value. Common discount 
rates are usually available from government 
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agencies; one option is to use interest rates on 
long-term government bonds.
Step 5: reading the economic savings resulting 
from reduced mortality
Results are presented in three different ways.
The average annual benefit is the value of lives 
saved (mortality only) per year. It averages the 
benefit over the time frame entered to calculate 
the benefits. This takes into account the time 
periods selected for uptake of walking and the 
build up of health benefits (see also section 5.3).
In addition, the total benefit accumulated over 
the time period entered for averaging the result 
is given as well as the maximum annual benefit 
achieved when both health benefits and uptake of 
walking have reached the maximum levels. These 
should always be quoted as maximum rather than 
average values.
The current value of the average annual benefit 
is the second main output of the model, using 
the discount rate from step 4 to calculate the net 
present value, taking into account the reduced 
value of benefits over time.
The current value of the total benefits accumulated 
over the time period entered is also shown.
If costs are entered, HEAT also provides a benefit–
cost ratio.
5.3. Assumptions
The results of the assessment depend on a 
number of assumptions, which were agreed at 
the consensus meeting.
The build-up of benefits is the estimated time it 
will take for walkers in the model to realize the 
benefits in terms of mortality of the walking 
entered at step 1. The default value is 5 years, 
based on expert consensus (see also section 2.8). 
If a steady-state situation is assessed (selecting 
“all current walking”), no build-up period for the 
health benefits is applied.
The average walking speed is set at 4.8 km/h 
(or 3 miles/hour). This is in line with the walking 
speed of the studies in the meta-analysis (where 
available) and equivalent to the minimum walking 
pace necessary to require an energy expenditure 
that is considered to be necessary for health 
benefits (13).
The relative risk data from the meta-analysis, 
which includes studies from China, Europe, Japan 
and the United States (see also section 3.2), can be 
applied to walkers in other settings.
There is a linear relationship between risk of 
death and walking duration (assuming a constant 
average speed), in other words, each dose of 
walking leads to the same absolute risk reduction.
No thresholds have to be reached to achieve 
health benefits.
Men and women have approximately the same 
level of relative risk reduction.
It is important to remember that many of the 
variables used within this HEAT calculation are 
estimates and therefore liable to some degree of 
error.
You are reminded that the HEAT tools provide 
you with an approximation of the level of health 
benefits. To get a better sense for the possible 
range of the results, you are strongly advised to 
rerun the model, entering slightly different values 
for variables where you have provided a “best 
guess”, such as entering high and low estimates 
for such variables.
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6.1. How to access the tool
The tool is available on the WHO Regional 
Office for Europe web site at www.euro.who.
int/HEAT (6) or directly from the HEAT site www.
heatwalkingcycling.org.
6.2. How to use the tool: five simple 
steps
6.2.1. General features of the HEAT web site 
HEAT is composed of 16 questions in total; 
depending on the route you take, some 
questions will be skipped. On the left-hand 
side of the screen you will see the flow chart of 
questions to help you orientate where you are in 
the assessment process.
Click on “next question” or “back” to move 
between questions; do not use the back-button 
of your internet browser. You can also go back 
to a previous question by clicking on it in the 
flow chart of questions on the left-hand side of 
the screen. If you make changes, click on “save 
changes” before you continue.
On all HEAT screens, by hovering with the mouse 
over an entry option, the relevant “hints and tips” 
box or boxes will be highlighted on the right- 
hand side of your screen. 
There is also a section with frequently asked 
questions, where further hints and tips can be 
found.
Step 1: entering cycling data
First of all, the scope for the use of HEAT needs to 
be considered to make sure that is applicable for 
an assessment (see also section 4.4).
If HEAT is right for the study in question, a 
decision needs to be taken as to which of the 
two possible data types is going to be used for 
the assessment.
• Data from a single point in time are used when 
assessing the status quo, such as valuing cur-
rent levels of cycling in a city, or if data on the 
results of an intervention only are available 
(no “before” data).
• Before and after data are used when assessing 
the impact of an actual intervention or 
hypothetical scenarios. Before and after 
data are required, and the tool evaluates the 
difference in levels of cycling between the 
two.
All assessments require two main parameters to 
be entered:
6 HEAT for cycling:  instructions for users
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1. the amount of cycling done in the study 
area as duration (the most direct entry 
route), distance or trips per day (more 
information on data sources is given in 
section 4.7); and
2. the number of people benefiting from this 
amount of cycling.
Amount of cycling: select the desired option for 
input data
Duration
Enter the average time spent cycling per person 
per day.
Distance
Enter the average time spent cycling per person 
per day.
Trips
If data are entered as trips, the average number 
of trips per person per day can be entered or the 
total number of trips observed in the study area 
(e.g. from a count of cyclists passing a sample 
point). If the total number of trips includes trips 
by modes of transport other than cycling, the 
mode share option can be used to take account 
of this by specifying the proportion of these trips 
that are cycling trips.
Then, either the total number of people taking 
these cycling trips or the proportion of these trips 
that are return journeys needs to be entered. 
For example, if 1000 trips a day are observed 
at a sample point, this could correspond to 
1000 individuals each counted once or 500 
individuals each counted twice (as they make a 
return journey), or some combination of the two. 
Whenever possible, it is strongly recommended 
to use the actual number of people cycling. 
This is because alternative methods involve a 
number of assumptions, which would reduce 
the accuracy of the results. If the total number 
of people taking these trips is unknown, the 
tool will use the proportion of return journeys 
to estimate the number of individuals taking 
the trips. As the HEAT web site assumes that the 
trip data you have entered relates to a regular 
(i.e. daily or near-daily) pattern of cycling, the 
number of individual cyclists is calculated from 
the proportion of return journeys, using the 
daily average number of trips. On the HEAT for 
cycling web site, input is given to derive the best 
proportion of return journeys for different types 
of count data.
Finally, the duration or distance of the cycling 
trips has to be entered.
For all entry options, the user also has to enter 
how many days per year this amount of cycling 
is done. If this amount is done every day (or 
represents an average value per year, e.g. 
from a travel survey), 365 should be entered. 
However, most individuals do not cycle every 
day. If no long-term data are used and users are 
unsure how many days they cycled in a year, 
124 is recommended as a default, which is the 
observed number of days in Stockholm (36). This 
is a conservative value, which should be changed 
only if reliable local data are available, as it will 
influence the final calculation.
If data from a single point in time are assessed, 
the user can then enter the general parameters. 
Otherwise, users will be asked to enter the 
after-intervention data. They can choose to use 
a different metric for the after data (e.g. duration 
for the before data and distance for the after 
data).
Number of people benefiting
The tool requires information on the number of 
individuals doing the amount of cycling entered 
in the previous questions.
In many cases, this figure will be the number of 
cyclists in the study area, city or country, or the 
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number of people who stand to benefit from 
the reported levels of cycling entered if the data 
were entered as cycling trips (see above).
In some cases, cycling data may have been 
derived from a survey based on a representative 
sample of a larger population, where the findings 
apply to the whole population. For example, 
in the case of a national travel survey that is 
representative of the whole population, the total 
population should be used here rather than the 
sample size of the travel survey.
It is important to ensure that the correct 
population figure is entered, as this can 
substantially affect the resulting calculations.
Step 2: checking the cycling summary
HEAT will now show a summary of the entries, 
allowing you to make corrections or to change 
entries. HEAT will also show the likely reduction 
in the risk of mortality in the study population, 
based on the entries (see also section 4.5).
Warning messages will appear here in two 
cases: (a) if levels of cycling have been entered 
that are above the suggested scope of HEAT for 
cycling of about 1 hour of cycling per day (see 
also section 4.4); and (b) if levels of cycling have 
been entered that would theoretically lead to 
very high reductions in the mortality rate.
Specifically, if an equivalent of 120 minutes or 
more of cycling per day is entered, users are 
requested to consider whether their entered 
volume of cycling truly represents long-term 
behaviour in an average adult population, as this 
is what HEAT is designed for. To avoid inflated 
values, the risk reduction available from the 
HEAT is capped at 45% (see also section 4.5).
Step 3: Impact of an intervention or all current 
cycling?
In this step, users can decide whether they want 
to quantify the benefits of a current situation (or 
a scenario analysis) in a country, in a community 
or on a specific infrastructure. This means that 
HEAT will provide an estimate of the value of all 
the cycling data entered (and no build-up period 
for the health benefits to accrue will be applied, 
see also section 4.8).
If  instead   “impact of an intervention” is selected, 
the tool will ask for an estimate of the proportion 
of the cycling that can be attributed to the 
intervention. When assessing the impact of an 
intervention, it is prudent to assume that not 
all the cycling or increase in cycling observed is 
newly induced.
Data to estimate the proportion of newly 
induced cycling are rarely available. Therefore, 
the proportion of cycling to be attributed to the 
intervention (i.e. to be evaluated) needs to be 
estimated to the best of the user’s knowledge. 
For guidance on this estimation, see the “hints 
and tips” box on this page.
It is strongly advised to calculate various 
scenarios with higher and lower percentages, 
as this number significantly affects your results.
Note that if users wish to assess the value of an 
increase of cycling over time without a particular 
intervention, 100% should be entered.
Time needed to reach full level of cycling
This allows adjustment for the estimated time it 
will take to reach the full level of cycling entered. 
This can be particularly useful when assessing 
interventions. For example, if a new cycle path 
is built and it is estimated it will take 5 years for 
usage to reach a steady state, this figure should 
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be changed to 5. The default value has been set 
at 1 year.
Step 4: checking the parameters
The parameters in step 4 have been set by the 
expert advisory group according to the best 
information currently available. They should be 
changed only if reliable local data are available, 
as changes to these parameters can have a 
significant impact on the final values.
Nevertheless, local values for the following two 
parameters should be used where available:
• For the value of a statistical life (in local 
currency), the standard value of a statistical 
life used in the country of study should be 
entered; the preferred currency can be chosen. 
This will form the basis of the cost savings 
in the model. Whenever possible, enter a 
country-specific value or use a country value 
from the drop-down menu (not available for 
Andorra, Monaco and San Marino). If this is 
not known, European default values of €2.487 
million (WHO European Region), €3.387 
million (EU-27 countries) or €3.371 million 
(EU-28 countries including Croatia) can be 
used (see section 2.12). These are based on 
a study by the OECD (23) that calculated an 
average VSL of US$ 3.6 million for the EU-27 
countries for 2005. This value was adjusted 
for income level differences across countries, 
inflation and income growth over time and 
conversion of the currency from USD to local 
currency, using purchasing power parity–
adjusted exchange rates (35). Regional default 
values were derived using the population 
weighted average of the country-specific VSL 
estimates.
• The annual rate of the working-age population 
that dies each year (deaths per 100 000 people 
per year in the respective age group) can 
be derived from published mortality data 
for people of working age for the study 
country. The default value is set at the last 
available average for the WHO European 
Region according to the WHO European 
Detailed Mortality Database (30). HEAT also 
provides national values as available in the 
WHO European Detailed Mortality Database 
(30). Users have the option to select default 
mortality rates for an average population 
(about 20–64 years old), a younger average 
population (about 20–45 years old) or a 
predominantly older average population 
(about 46–64 years old). It is suggested that 
the most recently available local rate be used 
wherever possible.
Users can also enter their own value. In this case, 
it is suggested to use the local crude annual 
death rate, as it reflects the age- and sex-specific 
mortality rates and the age and sex distribution 
of the population. Enter the number of deaths 
per year per 100 000 people aged 20–64 years. 
This allows the tool to focus on the age groups 
most likely to cycle and reflects the relative risk 
of all-cause mortality in that age group (see also 
sections 3.2 and 4.5). If the age distribution in 
the assessed population is significantly different 
(much younger or much older), HEAT may 
overestimate or underestimate the resulting 
benefits. In such cases, it is important to adjust 
the age range of the mortality rate used. However, 
it must be noted that HEAT is not appropriate for 
populations consisting mainly of children, very 
young adults or older people, as the underlying 
relative risk would not be appropriate.
The time frame for calculating mean annual 
benefit is the period over which the discounted 
mean annual benefit will be calculated. This is 
usually standardized within each country; the 
default value has been set at 10 years.
If it is known how much it cost to promote cycling 
in a particular case (such as a specific promotion 
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project or new infrastructure), and the user 
would like the tool to calculate a benefit–cost 
ratio for the local data, costs can be entered here. 
The costs must include all relevant investments. 
For example, to assess the benefit–cost ratio 
of a promotion campaign for cycling, costs for 
the cycling infrastructure used by the target 
audience, which may be borne by the local 
administration, will also need to be included. The 
time frame entered to calculate the benefit-cost 
ratio can differ from the time frame entered to 
calculate the average annual benefit (see above).
For the discount rate, the rate to be used for 
calculating future benefits can be entered. 
Savings that occur in future years will be 
discounted by this percentage per year, and will 
be shown in the “present value” section of Step 
5. A rate of 5% has been set as the default value. 
Common discount rates are usually available 
from government agencies; one option is to use 
interest rates on long-term government bonds.
Step 5. Reading the economic savings result-
ing from reduced mortality
Results are presented in three different ways.
The average annual benefit is the value of lives 
saved (mortality only) per year. It averages the 
benefit over the time frame entered to calculate 
the benefits. This takes into account the time 
periods selected for uptake of cycling and the 
build up of health benefits (see also section 5.3).
In addition, the total benefit accumulated over 
the time period entered for averaging the result 
is given as well as the maximum annual benefit 
achieved when both health benefits and uptake 
of cycling have reached the maximum levels. 
These should always be quoted as maximum 
rather than average values.
The current value of the average annual benefit 
is the second main output of the model, using 
the discount rate from Step 4 to calculate the net 
present value, taking into account the reduced 
value of benefits over time.
The current value of total benefit s accumulated 
over the time period entered is also shown.
If costs are entered, HEAT also provides a benefit–
cost ratio.
6.3. Assumptions
The results of the assessment depend on a 
number of assumptions, which were agreed at 
the consensus meetings.
• The build-up of benefits is the estimated 
time it will take for cyclists in the model to 
realize the benefits in terms of mortality of the 
cycling entered at step 1. The default value 
is 5 years, based on expert consensus (see 
also section 2.8). If a steady-state situation 
is assessed (selecting “all current cycling”), 
no build-up period for the health benefits is 
applied.
• The average cycling speed is set at 14 km/h. 
This value is based on commuting time per 
week from a study in Copenhagen (29), 
combined with data from the Stockholm 
commuting studies on the number of trips 
per week over the year, distance and dura-
tion (37,38). Based on an estimated average 
of 4 km per trip, the observed distance–speed 
relationship produces an estimated average 
speed of 14 km/h (38).
• The relative risk data from the meta-analysis, 
which includes studies from China and Europe 
(see also section 3.2), can be applied to cyclists 
in other settings.
• There is a linear relationship between risk 
of death and cycling duration (assuming a 
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constant average speed), in other words, each 
dose of cycling leads to the same absolute risk 
reduction.
• No thresholds have to be reached to achieve 
health benefits.
• Men and women have approximately the 
same level of relative risk reduction.
It is important to remember that many of the 
variables used within this HEAT calculation are 
estimates and therefore liable to some degree 
of error.
You are reminded that the HEAT tools provide 
you with an approximation of the level of health 
benefits. To get a better sense for the possible 
range of the results, you are strongly advised 
to rerun the model, entering slightly different 
values for variables where you have provided 
a “best guess”, such as entering high and low 
estimates for such variables.
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